Home > Cashflow Statement > IPCA LABORATORIES

IPCA LABORATORIES
Cashflow Statement

IPCA LABORATORIES is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

IPCA LABORATORIES Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹1,131 Cr₹843 Cr₹745 Cr₹1,136 Cr₹1,389 Cr
Adjustment ₹728 Cr₹490 Cr₹235 Cr₹195 Cr₹183 Cr
Changes In working Capital ₹-176 Cr₹-92 Cr₹49 Cr₹-273 Cr₹-236 Cr
Cash Flow after changes in Working Capital ₹1,683 Cr₹1,241 Cr₹1,029 Cr₹1,058 Cr₹1,336 Cr
Cash Flow from Operating Activities ₹1,321 Cr₹945 Cr₹806 Cr₹856 Cr₹1,090 Cr
Cash Flow from Investing Activities ₹-870 Cr₹-1,292 Cr₹-725 Cr₹-855 Cr₹-521 Cr
Cash Flow from Financing Activities ₹-283 Cr₹-553 Cr₹507 Cr₹427 Cr₹-306 Cr
Net Cash Inflow / Outflow ₹169 Cr₹-900 Cr₹588 Cr₹428 Cr₹264 Cr
Opening Cash & Cash Equivalents ₹756 Cr₹1,579 Cr₹991 Cr₹559 Cr₹295 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -₹77 Cr-₹4.12 Cr-
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹925 Cr₹756 Cr₹1,579 Cr₹991 Cr₹559 Cr

Compare Cashflow Statement of peers of IPCA LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
IPCA LABORATORIES ₹36,370.4 Cr -3.3% 2.1% -0.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,559.0 Cr 7.1% -1.5% -6.2% Stock Analytics
DIVIS LABORATORIES ₹164,827.0 Cr 2.8% -2.8% 6% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,942.0 Cr 3.1% 4.2% 18.8% Stock Analytics
CIPLA ₹106,825.0 Cr 0.2% -12.5% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,077.0 Cr 2.2% -1.6% 0% Stock Analytics


IPCA LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
IPCA LABORATORIES

-3.3%

2.1%

-0.3%

SENSEX

1.7%

-1.7%

10.3%


You may also like the below Video Courses